Infinitus
PrivateLast Round
Series C
Oct 23, 2024
Est. Valuation
$600M
Total Funding Raised
$102.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Infinitus is a healthcare technology company that provides an AI-powered agentic communications platform designed to automate administrative phone calls and workflows for healthcare providers, payers, and pharmacy benefit managers.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, Workflow Automation, Healthcare Analytics, Revenue Cycle, Low-Code/No-Code
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinitus Comparables
Compare Infinitus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notable | 85% | |
| Cohere Health | 83% | |
| Kore.ai | 81% |
For institutional investors. Book with your work email.
Infinitus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 23, 2024 | ||||
| Series B | Nov 10, 2021 | ||||
| Series A | Feb 5, 2021 | ||||
| Seed | May 3, 2019 |
For institutional investors. Book with your work email.
Infinitus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series C |
| Gradient Ventures | Seed, Series A |
| GV | Series C, Series B |
| Tau Ventures | Series A |
| Firebolt Ventures | Series A |
| Kleiner Perkins | Series B, Series C, Seed, Series A |
| Quiet Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Added Luther, a healthcare enterprise, as a customer.
- Jun 17, 2026
Added International Business Machines Corporation as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 7, 2026
Infinitus announces FieldForce, a set of secure AI agents that extends pharmaceutical field teams’ capacity before, after, and between healthcare provider interactions, in California on Oct 7th '26.
- launchesSep 9, 2026
In 2026, Infinitus rolls out changes to its Medicare offering that address new eligibility-check complexity, including automatic lookup of a member’s latest Medicare Beneficiary Identifier when the recorded one is invalid.
For institutional investors. Book with your work email.
Infinitus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Infinitus's valuation, stock price, and market status.
Is Infinitus a public or private company?
Infinitus is a private company.
What is the current stock price of Infinitus?
Infinitus is a private company, so its shares have no public market price. Caplight tracks Infinitus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Infinitus worth (valuation)?
Infinitus's valuation is estimated at $600.0M based on funding round data.
Can I buy Infinitus stock?
Infinitus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Infinitus's last funding round?
Infinitus's most recent funding round was Series C on October 23, 2024.
Who are the main investors in Infinitus?
Key investors in Infinitus include Andreessen Horowitz, GV, Kleiner Perkins, Coatue Management.
Will Infinitus IPO soon?
No public IPO plans have been announced for Infinitus.
How can I track Infinitus secondary market activity?
Caplight tracks bids, offers, and trades in Infinitus's shares on secondary markets.